TEZSPIRE

Google image searchProduct monograph

Active ingredient

tezepelumab, 110 MG/ML

DIN: 02529556

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE PRE-FILLED PEN

Schedule: Prescription / Schedule D

Company: ASTRAZENECA CANADA INC

Date: 19-OCT-2022

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
• R03DX — Other systemic drugs for obstructive airway diseases (ATC, ATC/DDD)
• R03DX11 — TEZEPELUMAB (ATC/DDD)

External Links for Tezspire

Search on Google

• Tezspire side effects
• Tezspire dosage
• tezepelumab side effects
• tezepelumab dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find tezspire photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.